Table 2.
Correlation between hsa_circ_0004831 expression and clinicopathological characteristics
| Characteristics | No. of patients | hsa_circ_0004831 (M ± SEM) | t value | p |
|---|---|---|---|---|
| Age (years) | ||||
| ≥ 50 | 45 | 5.59 ± 0.27 | 0.37 | 0.715 |
| < 50 | 36 | 5.73 ± 0.25 | ||
| Gender | ||||
| Male | 47 | 5.50 ± 0.23 | 1.06 | 0.291 |
| Female | 34 | 5.89 ± 0.29 | ||
| Distant metastasis | ||||
| M0 | 36 | 5.18 ± 0.28 | 2.43 | 0.018* |
| M1 | 45 | 6.06 ± 0.23 | ||
| TNM stage | ||||
| I + II | 33 | 5.75 ± 0.26 | 0.36 | 0.718 |
| III + IV | 48 | 5.61 ± 0.25 | ||
| Differentiation grade | ||||
| Well/moderate | 42 | 5.28 ± 0.24 | 2.26 | 0.027* |
| Poor | 39 | 6.09 ± 0.26 | ||
| Lymph node metastasis | ||||
| Negative | 35 | 5.70 ± 0.27 | 0.15 | 0.880 |
| Positive | 46 | 5.64 ± 0.25 | ||
* p < 0.05 was considered statistically significant